KOREA LIFE SCIENCE WEEK

2025 Exhibitors Search

Search Reset
All Number
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

※ Click on the participating company name below to see more information by company.

  • Mitos Therapeutics Inc. PARTNERING Treatment of Sarcopenia Korea, South E41
  • MolGenBio Co., Ltd. PARTNERING MolGenBio is developing a novel proprietary synthetic biology platform technology targeting intractable diseases such as neurodegenerative diseases and cancer. Our innovative and robust platform technology aims to develop the first/best-in-class small molecule therapeutics by harnessing the expertise in microbial genome scanning, editing and assembly. Our proprietary MTG (Molecule Through Gene) platform enables us to generate structural derivatives of small molecule drug candidates that are difficult to synthesize through the conventional medicinal chemistry approach. Our CEO/founder Prof Yoon at Seoul National University elucidated the complete biosynthetic pathway of FK506 for the first time. MolGenBio team has world-class expertise in tacrolimus R&D/manufacturing. Korea, South E41
  • MS Automation KOREA LIFE SCIENCE Imaging Module Korea, South C56
  • MyMedics Co.,Ltd. KOREA LIFE SCIENCE Auto-Cpap, Oxygen Concentrator, Cpap Supplies. Korea, South E46
처음페이지 12 마지막페이지